BioPharma APAC

World-first lung cancer screening facility increases chance of cure

The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...

December 01, 2021 | Influencers

Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech

The preclinical research also demonstrated Zantrene's ability to synergise with existing anthracyclines to better kill breast cancer cells. Due to signi...

November 22, 2021 | News

Carina Biotech and CellVec advances clinical trials, making strides for colorectal cancer treatment

Singapore-based viral vector CDMO supplies lentiviruses to Carina Biotech, advancing first in-human clinical trial for bowel cancer treatment ...

November 10, 2021 | News

Veracyte Announces Immunoscore Colon Cancer Test

Veracyte, Inc. today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO1 Clinical Practice Guideli...

November 08, 2021 | News

Freenome Shows Continued Leadership in Colorectal Cancer Research

Freenome, a privately held biotech company, presented new research at the American College of Gastroenterology (ACG) annual meeting that underscores their ...

October 26, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

October 26, 2021 | News

Rakuten,Karkinos Healthcare Announce Partnership to Expand Novel Cancer Care in India

Rakuten Medical is focused on developing and commercializing innovative cancer treatments for multiple indications based on its Illuminox™ platform. ...

October 25, 2021 | News

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

News Facts: - Aichi Cancer Center and Fujitsu jointly developed new AI solution to support physicians in efficiently choosing medical treatment expected t...

October 19, 2021 | News

Merck and Eisai Receive Positive EU CHMP Opinions

Positive Opinion Granted for Advanced Renal Cell Carcinoma Based on Significant Progression-Free Survival (PFS), Overall Survival (OS) and Objective Respon...

October 18, 2021 | News

Chinese Researcher Releases Latest Research Results on Early Screening for Multiple Cancers

Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week in Shanghai (IBIWS...

October 14, 2021 | News

Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announce...

October 08, 2021 | News

Japan to Encourages Breakthrough Cancer Research

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...

October 05, 2021 | News

Colorectal cancer diagnoses dropped over 40% during COVID-19 pandemic

The research, which was conducted across multiple hospitals in Spain, compared data from the first year of the COVID-19 pandemic with data from the pr...

October 04, 2021 | News

Zantrene® kills melanoma cancer cells that overproduce FTO

Zantrene® at low concentrations kills high FTO producing melanoma cancer cells Sensitivity to Zantrene® correlates with FTO levels, where high F...

September 30, 2021 | News

Stay Connected